Levels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Seixas, Magda O ^a,b   Rocha, Larissa C ^a,c   Carvalho, Mauricio B ^b   Menezes, Joelma F ^a,b   Lyra, Isa M ^b,c   Nascimento, Valma M ^c   Couto, Ricardo D ^b   Átta, Ájax M ^b   Reis, Mitermayer G ^a   Goncalves, Marilda S ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Fundacao de Hematologia e Hemoterapia do Estado da Bahia HEMOBA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 1 ANTITRYPSIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; CHOLESTEROL; HEMOGLOBIN; HEMOGLOBIN S; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTATE DEHYDROGENASE; TRIACYLGLYCEROL; UREA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; AUTACOID; LIPID;

ARTICLE; BILIRUBIN BLOOD LEVEL; BIOCHEMISTRY; BLOOD TRANSFUSION; CELL COUNT; CHILD; CHOLELITHIASIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HEART DISEASE; HEMATOCRIT; HEMATOLOGY; HUMAN; HYPERTRIGLYCERIDEMIA; IMMUNOASSAY; IMMUNOCHEMISTRY; INFANT; INFLAMMATION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOCYTE; PHENOTYPE; PNEUMONIA; PROGNOSIS; PROSPECTIVE STUDY; RETICULOCYTE; SCHOOL CHILD; SICKLE CELL ANEMIA; STEADY STATE; THROMBOCYTE; ADOLESCENT; BLOOD; BRAZIL; CONGENITAL HEART MALFORMATION; DYSLIPIDEMIA; HEMOLYSIS; MEDICAL RECORD; PATHOPHYSIOLOGY; PREVALENCE;

ADOLESCENT; ANEMIA, SICKLE CELL; BIOLOGICAL MARKERS; BRAZIL; CHILD; CHOLELITHIASIS; CHOLESTEROL, HDL; DYSLIPIDEMIAS; FEMALE; HEART DEFECTS, CONGENITAL; HEMOLYSIS; HUMANS; INFLAMMATION MEDIATORS; LIPIDS; MALE; MEDICAL RECORDS; PNEUMONIA; PREVALENCE; PROGNOSIS;

EID: 77955944271     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-91     Document Type: Article

References (31)

1. Clinical Aspects of sickle cell anemia in adults and children. K Ohene-Frempong MH Steinberg, Disorders of Hemoglobin: Genetics, In Patophysiology, and Clinical Management New York: Cambridge University Press, Steinberg MH, Forget BG, Higgs DR, Nagel RL, 2001 611 70
2. Sickle cell disease. MJ Stuart RL Nagel, Lancet 2004 364 1343 60 10.1016/S0140-6736(04)17192-4 15474138
3. General pathophysiology of sickle cell anemia. RL Nagel OS Platt, Disorders of Hemoglobin: Genetics, In Pathophysiology, and Clinical Management New York: Cambridge University Press, Steinberg MH, Forget BG, Higgs DR, Nagel RL, 2001 494 526
4. A network model to predict the risk of death in sickle cell disease. P Sebastiani VG Nolan CT Baldwin MM Abad-Grau L Wang AH Adewoye LC McMahon LA Farrer JG Taylor GJ Kato MT Gladwin MH Steinberg, Blood 2007 110 2727 2763 10.1182/blood-2007-04-084921 17600133
5. The intriguing contribution of white blood cells to sickle cell disease- a red cell disorder. I Okpala, Blood Reviews 2004 18 65 73 10.1016/S0268- 960X(03)00037-7 14684149
6. Role of adhesion molecules and vascular endothelium in the pathogenesis of sickle cell disease. MJ Telen, Hematology Am Soc of Hematol Educ Program 2007 2007 84 90
7. Platelet activation in patients with sickle cell disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. J Villagra S Shiva LA Hunter RF Machado MT Gladwin GJ Kato, Blood 2007 110 2166 2172 10.1182/blood-2006-12-061697 17536019
8. Adhesion molecule and hydroxyurea in the pathophysiology of sickle cell disease. C Johnson MJ Telen, Hematologica 2008 93 481 486 10.3324/haematol.12734
9. Serial review: Biomedial implications for hemoglobin interactions with nitric oxide. MT Gladwin JH Crawford RP Patel, Free Radical Biology & Medicine 2003 36 707 717
10. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. GJ Kato V McGowan RF Machado JA Little J Taylor CR Morris JS Nichols X Wang M Poljakovic SM Morris Jr MT Gladwin, Blood 2006 107 2279 2285 10.1182/blood-2005-06-2373 16291595
11. Serum lactate dehydrogenase activity as a biomarker in children with sickle cell disease. S O'Driscoll SE Height MC Dick DC Rees, Br J Haematol 2007 140 206 209 18028483
12. Subgroup studies of black admixture within a mixed population of Bahia, Brazil. ES Azevdo, Ann Hum Genet 1980 44 55 60 10.1111/j.1469-1809.1980.tb00945. x 6798920
13. Liver function and the diagnosis significance of biochemical changes in the blood of African children with sickle cell disease. UP Isichei, J Clin Pathol 1980 33 626 630 10.1136/jcp.33.7.626 7430368
14. A population study of renal function in sickle cell anemia. AH Skalar H Campbell RJ Caruana BO Lightfoot JG Gaier P Milner, Int J Artif Organs 1990 13 231 236 2373552
15. Acute renal failure in sickle cell anemia. AH Skalar JC Perez RJ Harp LRJ Caruana, Int J Artif Organs 1990 13 347 351 2379968
16. Comparison of renal function markers in Kuwaiti patients with sickle cell disease. R Marouf O Mojiminiyi N Abdella M Kortom H Al Wazzan, J Clin Pathol 2006 59 345 351 10.1136/jcp.2005.026799 16567469
17. Plasma and erythrocyte lipids in sickle cell anaemia. J Sasaki MR Waterman GR Buchanan GL Cottam, Clin Lab Haematol 1983 5 35 44 10.1111/j.1365-2257.1983.tb00494.x 6851435
18. Phase angle and n-3 polyunsaturated fatty acids in sickle cell disease. DJ VanderJagt YS Huang LT Chuang, Arch Dis Child 2002 87 252 254 10.1136/adc.87.3.252 12193445
19. Hypocholesterolemia in Nigerian children with sickle cell disease. DJ VanderJagt J Shores A Okorodudu SN Okolo RH Glew, J Trop Pediatr 2002 48 156 161 10.1093/tropej/48.3.156 12164599
20. Reduced cholesterol levels in African-American adults with sickle cell disease. J Shores J Peter son D Vanderjagt RH Gless, J Natl Med Assoc 2003 95 813 817 14527048
21. Serum lipids and atherogenic risk in sickle- cell trait carriers. S Djoumessi L Zekeng G Lando D Zeukeng, Ann Biol Clin 1994 52 663 665
22. Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension. S Zorca L Freeman M Hildesheim D Allen AT Remaley JG Taylor GJ Kato, Br J Haematol 2010 149 436 45 10.1111/j.1365-2141.2010.08109.x 20230401
23. Lipoprotein Cholesterol and Triglycerides in Children with steady-state sickle cell anemia [Abstract]. Seixas Magda Oliveira Rocha Larissa Carvalho Mauricio Menezes Joelma Lyra Isa Nascimento Valma Couto Ricardo Atta Ajax Reis Mitermayer Galvo Goncalves Marilda Souza, Blood 2009 114 1547
24. Endogenous cholesterol synthesis is associated with VLDL-2 apo-B100 production in healthy humans. BHCMT Prinsen JA Romiju PH Bisschop, J Lipid Res 2003 44 1341 1348 10.1194/jlr.M300023-JLR200 12700338
25. HDL arteriosclerosis: beyond reverse cholesterol transport. JR Nofer B Kehrel M Fobker B Levkau G Assmann A von Eckardstein, Atherosclerosis 2002 161 1 16 10.1016/S0021-9150(01)00651-7 11882312
26. Reverse cholesterol transport, high density lipoproteins and HDL cholesterol: recent data. A Fredenrich P Bayer, Diabetes Metab 2003 29 201 205 10.1016/S1262-3636(07)70029-0 12909808
27. Formation of pre1-HDL during lipolysis of triglyceride-rich lipoprotein. O Miyazaki I Fukamavhi A Mori, Biochem Biophys Res Commun 2009 379 55 59 10.1016/j.bbrc.2008.11.146 19070596
28. Mathematical modeling of competitive LDL/VLDL binding and update by hepatocytes. T Pearson JA Wattis B O'Malley, J Math Biol 2009 58 845 880 10.1007/s00285-008-0205-z 18704423
29. HDL and inflammatory response induced by LDL-derived oxidized phospholipids. M Navab JA Berliner G Subbanagounder S Hama AJ Lusis LW Castellani S Reddy D Shih W Shi AD Watson BJ Van Lenten D Vora AM Fogelman, Arterioscler Thromb Vasc Biol 2001 21 481 488 11304461
30. The oxidation hypothesis hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. M Navab GM Ananthramaiah ST Reddy, J Lipid Res 2004 45 9932 1007 10.1194/jlr.R400001-JLR200 (Pubitemid 38679495)
31. Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. CP Minniti C Sable A Campbell S Rana G Ensing N Dham O Onyekwere M Nouraie GJ Kato MT Gladwin OL Castro VR Gordeuk, Haematologica 2009 94 340 347 10.3324/haematol.13812 19211639